Prevalence and risk factors of diabetic neuropathy in Qassim, Saudi Arabia

Abstract

Background and Aim: Diabetic neuropathy is the commonest early and long-term complication of diabetes. Saudi Arabia has a high prevalence of diabetic neuropathy reaching (65%), which necessitate the establishment of a preventive program. The aim of the study was to measure the prevalence of diabetic neuropathy and its associated risk factors in Qassim, Saudi Arabia. Methods: A cross-sectional study that utilized an adopted a translated version of Michigan neuropathy screening instrument. An electronic questionnaire was filled by each participant after obtaining inform consent. The questionnaire included questions about neuropathy in addition to added questions about demography of participants. After data collection, SPSS version 21.00 was used for data analysis. Results: A total of 374 patients has been included in the analysis. Of which (54%) were females, and (97.1%) were Saudis with a neuropathy was (38.2%). Significant associations with abnormal total scores included; low education (p≤ 0.007), hypertension (p ≤ 0.017), high body mass index (p < 0.001), use of insulin and/or multidrug for diabetes (p < 0.001). Further analysis of sex, age, and smoking did not show any significance with diabetic neuropathy. Conclusions: Our study concluded that more than one third of diabetics in Qassim region are having diabetic neuropathy. Paying attention to risk factors is an important factor for early detection of the condition.

References

1. 1.Naeem Z. Burden of Diabetes Mellitus in Saudi Arabia. International Journal of Health Sciences 2015;9(3):5-6.
2. 2.Sheshah E,Algreeshah F,Al-Madani K,Al 30 Majmaah Journal of Health Sciences ,Vol. 8, Issue 2, May - 2020 , Ramadan - 1441 Prevalence and risk factors of diabetic neuropathy in Qassim, SaudiArabia Qaisi D, Madanat A. Diabetic peripheral neuropathy and sudomotor dysfunction in Saudi patients with newly diagnosed type 2 diabetes mellitus. J Diabetes Metab Disord Control 2017;4(2):70‒72.
3. 3.Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diab Care 2006; 29(7): 1518-1522.
4. 4.Petropoulos IN, Javed S,Azmi S, KhanA, Ponirakis G, Malik RA. Diabetic neuropathy and painful diabetic neuropathy in the Middle East and North Africa (MENA) region: Much work needs to be done. J Taibah Univ Med Sc 2016;11(4):284e294.
5. 5.Javed S, Petropoulos IN, Tavakoli M, Malik RA. Clinical and diagnostic features of small fiber damage in diabetic polyneuropathy. Handb Clin Neurol 2014; 126: 275e290.
6. 6.Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy:Where are we now and where to go? Journal of Diabetes Investigation 2011;2(1):18-32.
7. 7.Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, et al. Diabetic neuropathies a statement by the American Diabetes Association. Diabetes Care. 2005;28:956–62.
8. 8.Kahn RC, Weir CG. Diabetes Mellitus. 13th edition. Pennsylvania, Lea & Febiger inc;1994. [9]Tesfaye S.Advances in the management of diabetic peripheral neuropathy. Current Opinion in Supportive and Palliative Care 2009, 3:136–143.
9. 9.General authority for statistics, Kingdom of Saudi Arabia. Home > services guide > the twelfth guide 2001 > Inventory services in cities and villages by Administrative Regions. (Accessed 6th December 2018). Available from: https://www.stats.gov.sa/en/106.
10. 10.Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med. 2012;29(7):937-44.
11. 11.Abbott CA1, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes care. 2011;34(10):2220-4.
12. 12.Garoushi, Sabri & Johnson, Mark & Tashani, Osama. Point Prevalence of Painful Diabetic Neuropathy in the Middle East and North Africa Region: A Systematic Review with Meta-analysis 2018;2(3):86-89. Majmaah Journal of Health Sciences ,Vol. 8, Issue 2, May - 2020 , Ramadan - 1441 31 Prevalence and risk factors of diabetic neuropathy in Qassim, SaudiArabia
13. 13.Vesti Nielsen, Jørgen. Peripheral neuropathy, hypertension, foot ulcers and amputations among Saudi Arabian patients with type 2 diabetes Diabetes Research and Clinical Practice 1998;41(1):63-69.
14. 14.Akbar, Daad. Diabetic Neuropathy: Discordance between Symptoms and ElectrophysiologicalTesting in Saudi Diabetics. Bahrain Medical Bulletin 2002;24: 10-12.
15. 15.Mojaddidi M, Aboonq M, Al Nozha O, Abdulkadir SA, Elbab MF. Early Diagnosis of Diabetic Neuropathy inAlmadinahAlmunawwarah. Journal of Taibah University Medical Sciences. 2011;6:121-31.
16. 16.Wang DD, Bakhotmah BA, Hu FB, Alzahrani HA. Prevalence and correlates of diabetic peripheral neuropathy in a Saudi Arabic population: a cross-sectional study. PloS one. 2014;9(9):1-8.
17. 17.AlQuliti KW. Predictors of Painful Diabetic Neuropathy in Saudi Patients with Type 2 Diabetes: A Case-Control Study. J Pain Relief 2015;4:181.
18. 18.Goweda, Reda. Assessment of Knowledge and Practices of Diabetic Patients Regarding Diabetic Foot Care, in Makkah, Saudi Arabia. Journal of Family Medicine and Health Care 2017;3(1):17-22.
19. 19.Algeffari, Metab A. Painful Diabetic Peripheral Neuropathy among Saudi Diabetic Patients is Common but Under-recognized: Multicenter Cross-sectional study at primary health care setting. Journal of family & community medicine 2018;25(1):43-47.
20. 20.Kasim K & Al Nozha O. Prevalence and risk factors fo peripheral neuropathy in diabetic patients attending prince Abdul Aziz Bin Majed diabetes centre in Madinah, Saudi Arabia. Journal of disease and global health 2015;2:1-7.
21. 21.Elhadd T, Al-Amoudi AA, Alzahrani A. Epidemiology, Clinical and Complications Profile of Diabetes in SaudiArabia:AReview. Annals of Saudi medicine. 2007;27:241-50.
22. 22.Omar MS, Khudada K, Safarini S, Mehanna S, Nafach J. DiabCare survey of diabetes management and complications in the Gulf countries. Indian J Endocr Metab 2016;20:219-27